MarketPeel
Insider Trading Intelligence
NA

Nadim Ahmed

BMY
PRESIDENT, HEMATOLOGY · BRISTOL MYERS SQUIBB CO · CIK 0001731193
FILING MIX · LIFETIME58%/42%
BUYS
26
SELLS
19
TOTAL VALUE
$2.39M
COMPANIES
3
ACTIVE SINCE
Nov 2019
HOLDINGS NOW
434,868
AVG SELL PX
$24.61
TRADE KIND
SHOWING 45 / 45
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 10 pending
Forward-return performance of every backtestable P/S trade by Nadim Ahmed, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+54.55%+1.92%-0.89%+2.81%+1.80%
14d11+45.45%+4.22%-0.91%+5.13%+5.96%
30d11+63.64%+5.75%-0.03%+5.78%+1.13%
60d11+54.55%+11.47%+2.84%+8.64%+2.15%
90d11+54.55%+9.61%+2.65%+8.28%+8.83%
180d11(2 pending)+66.67%+4.40%+7.73%-3.33%-16.45%
1y11(3 pending)+25.00%+52.81%+22.93%+29.88%+23.81%
2y11(5 pending)+83.33%+1.14%+42.66%-41.52%-59.31%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BMY · 38,889 shares · as of Dec 31, 2020
011,63723,27534,91246,5492020SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 26 buys / 19 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
5,1765,176Jun 18, 2026Jun 23, 2026View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
13,515$14.47$195.6K390,803Feb 24, 2026Feb 25, 2026View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
16,381$13.62$223.1K404,318Feb 20, 2026Feb 23, 2026View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
828,000828,000Feb 18, 2026Feb 19, 2026View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
9,922$10.01$99.3K420,699Dec 23, 2025Dec 29, 2025View →
IRON
DISC MEDICINE, INC.
PURCHASEGRANT
Stock grant
20,00020,000Jul 14, 2025Jul 16, 2025View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
12,529$8.53$106.9K430,621Feb 25, 2025Feb 27, 2025View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
180,000443,150Feb 19, 2025Feb 21, 2025View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
360,000360,000Feb 19, 2025Feb 21, 2025View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
8,400$11.87$99.7K263,150Dec 24, 2024Dec 27, 2024View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
160,000271,550Feb 22, 2024Feb 23, 2024View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
320,000320,000Feb 22, 2024Feb 23, 2024View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
4,272$9.24$39.5K111,550Dec 26, 2023Dec 27, 2023View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
759$11.40$8.7K115,822Jun 28, 2023Jun 29, 2023View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
707$9.15$6.5K116,581May 23, 2023May 24, 2023View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
716$10.59$7.6K117,288Apr 25, 2023Apr 26, 2023View →
CGEM
CULLINAN THERAPEUTICS, INC.
SALE
President and CEO
706$10.51$7.4K118,004Mar 23, 2023Mar 27, 2023View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
109,000118,710Feb 22, 2023Feb 23, 2023View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
211,000211,000Feb 22, 2023Feb 23, 2023View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,620$10.90$17.7K9,710Jun 30, 2022Jul 5, 2022View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASE
President and CEO
8,090$12.40$100.3K8,090Jun 6, 2022Jun 7, 2022View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
215,000215,000Mar 5, 2022Mar 7, 2022View →
CGEM
CULLINAN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,710,0002,710,000Oct 18, 2021Oct 20, 2021View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
EVP and President, Hematology
14,9460Dec 31, 2020Jan 5, 2021View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
EVP and President, Hematology
14,94646,549Dec 31, 2020Jan 5, 2021View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
EVP and President, Hematology
7,660$62.03$475.1K38,889Dec 31, 2020Jan 5, 2021View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
EVP and President, Hematology
6,59419,782Dec 2, 2020Dec 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
EVP and President, Hematology
3,380$62.18$210.2K31,603Dec 2, 2020Dec 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
EVP and President, Hematology
6,59434,983Dec 2, 2020Dec 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
EVP and President, Hematology
4,6500Oct 30, 2020Nov 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
EVP and President, Hematology
4,65030,680Oct 30, 2020Nov 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
EVP and President, Hematology
2,291$58.45$133.9K28,389Oct 30, 2020Nov 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
EVP and President, Hematology
1,433$60.26$86.4K26,030May 1, 2020May 5, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
EVP and President, Hematology
2,90827,463May 1, 2020May 5, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
EVP and President, Hematology
2,9080May 1, 2020May 5, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASEGRANT
Stock grant
32,08232,082Mar 10, 2020Mar 12, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASEGRANT
Stock grant
21,38821,388Mar 10, 2020Mar 12, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
President, Hematology
17,20434,410Mar 1, 2020Mar 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
President, Hematology
8,473$59.06$500.4K24,555Mar 1, 2020Mar 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
President, Hematology
17,20433,028Mar 1, 2020Mar 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
President, Hematology
2,0764,152Feb 4, 2020Feb 6, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASE
President, Hematology
2,07616,895Feb 4, 2020Feb 6, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
SALE
President, Hematology
1,071$64.29$68.9K15,824Feb 4, 2020Feb 6, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASEGRANT
Stock grant
14,94614,946Nov 20, 2019Jan 3, 2020View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASEGRANT
Stock grant
33,18333,183Nov 20, 2019Jan 3, 2020View →
Other insiders · BMY
Loading peer insiders…
About this filer
CIK 0001731193
ROLE
President, Hematology
PRIMARY
BMY
COMPANIES
3
ACTIVE SINCE
Nov 2019
MARKETPEEL · /INSIDER/0001731193DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback